GenomeUp
PrivateLast Round
VC Round
Apr 3, 2025
Total Funding Raised
$2.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GenomeUp operates in Healthcare & Life Sciences and is based in Rome. Its latest recorded funding round was a VC Round in April 2025.
GenomeUp is a health-tech company that develops an AI-powered software-as-a-medical-device platform for genomic analysis and clinical decision support in rare diseases and oncology.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Healthcare Analytics, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenomeUp Comparables
Compare GenomeUp with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| enGenome | 90% | |
| Limbus Medical Technologies GmbH | 86% | |
| Geneyx | 85% |
For institutional investors. Book with your work email.
GenomeUp Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 3, 2025 | ||||
| Seed | Mar 16, 2023 | ||||
| Seed | Feb 8, 2022 | ||||
| Accelerator | Aug 6, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GenomeUp Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zest S.p.A. | Accelerator |
| The Techshop | VC Round |
| Lumen Ventures | Seed |
| CDP Venture Capital SGR | VC Round |
| Padda Health | Seed |
| Opes Italia SICAF EuVECA | VC Round |
| Scientifica Venture Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 59% MoM.
- Jun 20, 2026
Monthly visitors grew 187% MoM, reaching 872.
For institutional investors. Book with your work email.
GenomeUp Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenomeUp's valuation, stock price, and market status.
Is GenomeUp a public or private company?
GenomeUp is a private company.
What is the current stock price of GenomeUp?
GenomeUp is a private company, so its shares have no public market price. Caplight tracks GenomeUp's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenomeUp worth (valuation)?
Valuation information for GenomeUp is not publicly available.
Can I buy GenomeUp stock?
GenomeUp shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenomeUp's last funding round?
GenomeUp's most recent funding round was VC Round on April 3, 2025.
Who are the main investors in GenomeUp?
Key investors in GenomeUp include Zest S.p.A., The Techshop, Lumen Ventures.
Will GenomeUp IPO soon?
No public IPO plans have been announced for GenomeUp.
How can I track GenomeUp secondary market activity?
Caplight tracks bids, offers, and trades in GenomeUp's shares on secondary markets.